| | | DRS group
| | Control group
|
| | Gender (M : F) | 2 : 18 | 0,05 | 6 : 18 | | Age mean (SD)] | 63,9 (6,6) | 0,05 | 65,9 (10,3) | | BMI median (; )] | 28,5 (24,9; 33,6) | 0,05 | 27,8 (24,3; 29,3) | | Smoking (%) | 6 (30%) | 0,05 | 3 (12,5%) | | Diabetes mellitus (%) | 6 (30%) | 0,05 | 2 (8,3%) | | Hypertension (%) | 17 (85%) | 0,05 | 19 (79,2%) | | Hyperlipidemia (%) | 13 (65%) | 0,05 | 12 (50%) | | Medications (%) | | | | | ACE inhibitor | 7 (35%) | 0,05 | 12 (50%) | | Acetylsalicylic acid | 3 (15%) | 0,05 | 4 (17%) | | -blocker | 7 (35%) | 0,05 | 10 (42%) | | Ca antagonist | 3 (15%) | 0,05 | 8 (34%) | | Diuretic | 7 (35%) | 0,05 | 6 (25%) | | Statin | 6 (30%) | 0,05 | 5 (21%) | | Insulin | 2 (10%) | 0,05 | 2 (8,3%) | | Oral antidiabetic agents | 2 (10%) | 0,05 | 2 (8,3%) |
|
|
